Who is sponsoring NCT04711434?

NCT04711434 is sponsored by Sun Yat-sen University.

What condition does NCT04711434 study?

NCT04711434 studies Lynch Syndrome.

What is the status of NCT04711434?

NCT04711434 is currently UNKNOWN.

Last reviewed 2021-01-20 · How we verify

PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients

NCT04711434 PHASE3 UNKNOWN

This study aims to explore the role of PD-1 Antibody in preventing adenomatous polyps and second primary tumors in patients with Lynch Syndrome. There two arms, one is the experimental arm (PD-1 antibody prevention group) and the other is the control arm (routine follow-up group). For the experimental group, Tripleitriumab (PD-1 antibody) is given every 3 months for a year.

Details

Lead sponsor	Sun Yat-sen University
Phase	PHASE3
Status	UNKNOWN
Enrolment	260
Start date	Sun Nov 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Lynch Syndrome

Interventions

PD-1 Antibody

Countries

China